Antiplatelet therapy following TAVI: Time to randomise

Netherlands Heart Journal

Volumn 22, Issue 2, 2014, Pages 62-63

  Delewi, R ^a   Piek, J J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CLOPIDOGREL; THIENOPYRIDINE DERIVATIVE;

ANTICOAGULANT THERAPY; AORTA STENOSIS; ARTIFICIAL EMBOLISM; BLEEDING; BRAIN INFARCTION; CEREBRAL EMBOLISATION; CEREBROVASCULAR ACCIDENT; CLINICAL DECISION MAKING; DUAL ANTIPLATELET THERAPY; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; META ANALYSIS (TOPIC); MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; TRANSCATHETER AORTIC VALVE IMPLANTATION;

EID: 84897089681     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/s12471-013-0507-7     Document Type: Editorial

References (5)

1. Nuis RJ, van MieghemNM, Schultz CJ, et al. Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol. 2012;109:1637-43.
2. Hassell ME, Nijveldt R, Roos YB, et al. Silent cerebral infarcts associated with cardiac disease and procedures. Nat Rev Cardiol. 2013;10:696-706.
3. Genereux P, Head SJ, van MieghemNM, et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317-26.
4. Borz B, Durand E, GodinM, et al. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis. Heart. 2013;99:860-5.
5. Nijenhuis VJ, Stella PR, Baan J, et al. Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals. Neth Heart J 2013. doi:10.1007/s12471-013-0496-6.